Thomas Schröter - Concepedia

Author

Thomas Schröter

Scripps Research Institute

Also Known As

Thomas Schröter

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute University of Miami Goethe University Frankfurt

About

Thomas Schröter is an author at Scripps Research Institute specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	529
2	Natural Sciences	9	9	261
3	Biochemistry	9	9	287
4	Cell Biology	2	2	50
5	Cellular Physiology	2	2	50

Thomas Schröter

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Clathrin‐ and Dynamin‐Dependent Coated Vesicle Formation from Isolated Plasma Membranes Ishido Miwako, Thomas Schröter, Sandra L. Schmid Traffic	2003	160
Mutational analysis of residues forming hydrogen bonds in the Rieske [2Fe‐2S] cluster of the cytochrome <i>bc</i><sub>1</sub> complex in <i>Paracoccus denitrificans</i> Thomas Schröter, O. Hatzfeld, Sabine Gemeinhardt, European Journal of Biochemistry	1998	97
Benzimidazole- and benzoxazole-based inhibitors of Rho kinase E. Hampton Sessions, Yan Yin, Thomas D. Bannister, Bioorganic & Medicinal Chemistry Letters Rho KinaseMedicineMechanism Of ActionPharmacotherapyAnti-cancer Agent	2008	89
Discovery of Substituted 4-(Pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors Yangbo Feng, Yan Yin, Amiee Weiser, Journal of Medicinal Chemistry	2008	88
AAK1‐Mediated μ2 Phosphorylation is Stimulated by Assembled Clathrin S. D. Conner, Thomas Schröter, Sandra L. Schmid Traffic	2003	78
Tetrahydroisoquinoline Derivatives As Highly Selective and Potent Rho Kinase Inhibitors X. M. Fang, Yan Yin, Yen‐Ting Chen, Journal of Medicinal Chemistry Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryBiochemistryRho Kinase	2010	60
Chroman-3-amides as potent Rho kinase inhibitors Yen‐Ting Chen, Thomas D. Bannister, Amiee Weiser, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineReceptor Tyrosine KinasePharmacotherapyAnti-cancer Agent	2008	48
Structure–activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II Yangbo Feng, Michael D. Cameron, B. Frąckowiak, Bioorganic & Medicinal Chemistry Letters Pharmaceutical SciencePharmacological StudyIndazole PiperazineDrug DiscoveryMedicine	2006	45
Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I) Sarwat Chowdhury, E. Hampton Sessions, Jennifer Pocas, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryRho KinaseNatural Sciences	2011	44
Comparison of Miniaturized Time-Resolved Fluorescence Resonance Energy Transfer and Enzyme-Coupled Luciferase High-Throughput Screening Assays to Discover Inhibitors of Rho-Kinase II (ROCK-II) Thomas Schröter, Dmitriy Minond, Amiee Weiser, SLAS DISCOVERY	2008	44

Page 1